(RTTNews) - Jade Biosciences, Inc. (JBIO), on Monday announced the presentation of new preclinical data for JADE101, its anti-APRIL monoclonal antibody candidate for the treatment of IgA nephropathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback